Expert perspectives on Myalgic encephalomyelitis/chronic fatigue syndrome - Insights from the 3<sup>rd</sup> International Conference of the Charité Fatigue Center. — ME/CFS Atlas
Expert perspectives on Myalgic encephalomyelitis/chronic fatigue syndrome - Insights from the 3rd International Conference of the Charité Fatigue Center.
Fehrer, Annick, Windzio, Lara, Schoening, Simon et al. · Autoimmunity reviews · 2026 · DOI
Quick Summary
Nearly 4,000 ME/CFS researchers and experts gathered at an international conference in May 2025 to share the latest discoveries about this serious illness. They discussed how ME/CFS develops, better ways to diagnose it, and new treatments being tested. The conference highlighted that while COVID-19 has brought more attention and funding to ME/CFS research, the disease is still not well understood and needs much more study.
Why It Matters
This summary of expert consensus from a major international conference provides patients and clinicians with a comprehensive overview of current research priorities and emerging understanding of ME/CFS mechanisms. The emphasis on the urgent need for sustained, adequately funded research reflects the scientific community's recognition that ME/CFS causes severe disability yet remains poorly understood compared to other chronic diseases.
Observed Findings
Conference brought together ~200 on-site researchers and ~3,700 online participants from multiple disciplines
Key pathophysiological topics presented included cardiovascular dysregulation, immune dysregulation, autoimmune mechanisms, and metabolic dysfunction
Clinical trials targeting autoantibodies were presented and discussed
Increased public awareness and funding opportunities have emerged following the COVID-19 pandemic
Post-COVID syndrome (PCS) was identified as a major focus alongside classic ME/CFS
Inferred Conclusions
ME/CFS remains severely underresearched despite its significant impact on quality of life and increasing prevalence
Multiple pathophysiological mechanisms are likely involved in ME/CFS, requiring interdisciplinary research approaches
Pandemic-related increases in awareness and funding, while helpful, remain insufficient for adequate investigation
Sustained and adequately funded research efforts are urgently needed to identify diagnostic markers and develop targeted therapies
Remaining Questions
Which pathophysiological mechanisms (cardiovascular, immune, autoimmune, metabolic) are primary versus secondary in ME/CFS pathogenesis?
What This Study Does Not Prove
As an editorial summary of a conference rather than a primary research study, this does not present new experimental data or prove specific diagnostic criteria or treatments are effective. It does not establish causal mechanisms for ME/CFS or validate any single pathophysiological model, but rather reflects expert consensus on areas requiring further investigation.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.